CG Oncology, Inc. Common stock Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.1M | 2.3M | 1.7M | 0 | 52K | 456K | 43K | 111K |
| Cost of Goods Sold | 3.0M | 2.9M | 1.6M | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -1.9M | -592K | 89K | 0 | 52K | 456K | 43K | 111K |
| R&D Expenses | 43.7M | 30.0M | 27.9M | 31.3M | 27.5M | 26.8M | 19.6M | 18.5M |
| Operating Expenses | 64.5M | 48.1M | 51.2M | 48.7M | 42.3M | 38.5M | 28.3M | 26.0M |
| Operating Income | -66.4M | -48.7M | -51.1M | -48.7M | -42.2M | -38.0M | -28.3M | -25.9M |
| Other Income / Gains | 6.2M | 7.4M | 7.3M | 7.3M | 7.8M | 6.3M | 7.9M | 7.0M |
| Net Income | -60.2M | -41.3M | -43.8M | -41.4M | -34.5M | -31.8M | -20.4M | -18.9M |
| EPS (Diluted) | -0.71 | -0.52 | -0.57 | -0.54 | -0.45 | -0.49 | -0.30 | -0.28 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | -1.735 | -0.255 | 0.053 | 0 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 20.8M | 18.0M | 23.3M | 17.4M | 14.8M | 11.7M | 8.7M | 7.5M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 20.8M | 18.0M | 23.3M | 17.4M | 14.8M | 11.7M | 8.7M | 7.5M |
| Other Expenses | 0 | 155K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 67.5M | 51.0M | 52.8M | 48.7M | 42.3M | 38.5M | 28.3M | 26.0M |
| Interest Income | 6.3M | 22.5M | 7.4M | 7.3M | 7.7M | 6.2M | 7.9M | 6.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 841K | 849K | 416K | 156K | 24K | -32K | 21K | 7K |
| Ebitda | -65.5M | -40.5M | -43.4M | -48.6M | -42.2M | -38.0M | -28.3M | -25.8M |
| Ebitdaratio | -60.524 | -17.425 | -26.046 | 0 | -811.154 | -83.441 | -657.535 | -232.847 |
| Operating Income Ratio | -61.301 | -20.973 | -30.69 | 0 | -811.615 | -83.441 | -658.023 | -232.91 |
| Income Before Tax | -60.2M | -41.3M | -43.8M | -41.4M | -34.5M | -31.8M | -20.4M | -18.9M |
| Income Before Tax Ratio | -55.588 | -17.79 | -26.295 | 0 | -662.538 | -69.732 | -474.535 | -170.288 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -55.588 | -17.79 | -26.295 | 0 | -662.538 | -69.732 | -474.535 | -170.288 |
| Epsdiluted | -0.71 | -0.52 | -0.57 | -0.54 | -0.45 | -0.49 | -0.30 | -0.28 |
| Weighted Average Shs Out | 84.5M | 77.3M | 76.7M | 76.2M | 76.2M | 64.8M | 67.1M | 66.6M |
| Weighted Average Shs Out Dil | 84.5M | 77.3M | 76.7M | 76.2M | 76.2M | 64.8M | 67.1M | 66.6M |